Analyst Ratings January 29, 2026

KeyBanc Lifts Meta Price Target to $855, Citing AI-Driven Productivity Gains

Analyst keeps Overweight rating as revenue momentum and infrastructure plans support a bullish revenue outlook

By Sofia Navarro META
KeyBanc Lifts Meta Price Target to $855, Citing AI-Driven Productivity Gains
META

KeyBanc Capital Markets increased its price target on Meta Platforms Inc. to $855 from $835 while retaining an Overweight recommendation. The upgrade follows what the firm described as a "blue-sky scenario" in Meta's fourth-quarter results, with the bank highlighting agentic coding-driven productivity gains, robust revenue growth, and infrastructure expansion that together underpin expectations for more than $90 billion in additional revenue between 2025 and 2027.

Key Points

  • KeyBanc raised its price target on Meta to $855 from $835 and retained an Overweight rating.
  • Meta trades at $668.73 with a $1.69 trillion market cap, an 82.01% gross profit margin, and 21.27% revenue growth over the past year.
  • Multiple brokerages raised or maintained Buy ratings, with price targets clustering between $820 and $940, reflecting positive sentiment across technology and advertising sectors.

KeyBanc Capital Markets has raised its target price for Meta Platforms Inc. to $855 from $835 and continues to carry an Overweight rating on the shares. The firm pointed to the company's fourth-quarter results and accompanying metrics as the basis for the move.

Meta is trading at $668.73 and has a market capitalization of $1.69 trillion. The company reports a gross profit margin of 82.01% and achieved 21.27% revenue growth over the last twelve months. These figures figure prominently in KeyBanc's reassessment of Meta's medium-term earnings trajectory.

KeyBanc characterized the fourth-quarter snapshot as a "blue-sky scenario," noting that although operating expenses and capital expenditures increased, the company offset those costs with a favorable revenue growth outlook and multiple indicators of value being delivered from artificial intelligence initiatives. The firm specifically pointed to agentic coding as a driver of material improvements in engineering productivity at the social media giant.

Beyond productivity, KeyBanc cited infrastructure growth as a complementary force. The analyst firm now expects Meta to add in excess of $90 billion of revenue during the 2025-2027 period, and it said concerns around return on investment have eased in light of the company’s recent disclosures and internal metrics.

The newly set $855 price target corresponds to a multiple of 25 times KeyBanc's estimated 2027 price-to-earnings for Meta. By comparison, the company currently trades at a P/E ratio of 29.65 and posts a PEG ratio of 4.21, which the firm notes implies Meta is trading at a premium relative to near-term earnings growth.

Independent valuation models show a range of analyst targets for the stock. Those targets run from $685 at the low end to $1,117 at the high end, and one comprehensive fair-value assessment indicated the shares are fairly valued under that model.

Other brokerages and research houses have also updated their views following Meta’s most recent results. Loop Capital reiterated a Buy rating with a $940 target. Stifel described results as "very healthy," raised its price objective to $820 and kept a Buy stance, pointing out that revenue exceeded the high end of guidance. Evercore ISI increased its target to $900 and cited about a 25% potential upside based on its earnings outlook. Canaccord Genuity adjusted its target to $930 after noting that Meta’s revenue and operating income beat consensus by roughly 3%, with advertising revenue up 23% year over year on a foreign-exchange-neutral basis. DA Davidson raised its target to $850 while maintaining a Buy rating.

Taken together, these analyst actions reflect a broadly positive tone among sell-side firms regarding Meta’s near-term results and medium-term prospects, driven by revenue momentum, AI-related productivity gains, and continued infrastructure investment.


Key points

  • KeyBanc raised Meta's price target to $855 from $835 and kept an Overweight rating, citing Q4 results and AI-driven productivity gains.
  • Meta is trading at $668.73 with a $1.69 trillion market cap, 82.01% gross profit margin, and 21.27% revenue growth over the past year.
  • Several brokerages raised or maintained Buy ratings with price targets ranging from $820 to $940, reflecting broadly positive analyst sentiment across the tech and advertising sectors.

Risks and uncertainties

  • Higher operating expenses and capital expenditures - These cost increases were highlighted in the fourth-quarter results and remain a factor for profitability and cash deployment.
  • Valuation premium - Meta currently trades at a P/E of 29.65 and a PEG of 4.21, indicating the shares are priced with premium expectations for near-term earnings growth.
  • Dependence on AI and infrastructure outcomes - The anticipated revenue additions and improved returns on investment rely on the realization of AI productivity gains and successful infrastructure expansion.

Risks

  • Rising operating expenses and capital expenditures could pressure profitability and returns - impacts corporate margins and technology infrastructure spending.
  • Current valuation metrics (P/E of 29.65 and PEG of 4.21) suggest the stock trades at a premium to near-term earnings growth - affects investors' expected returns in equity markets.
  • Revenue and return projections depend on AI-driven productivity gains and infrastructure deployment - outcomes could influence technology and digital advertising sectors.

More from Analyst Ratings

HSBC Lowers Synopsys Rating to Hold, Flags 2026 as Transition Year Feb 21, 2026 DA Davidson Cuts Uber Price Target Citing Elevated Investment; Buy Rating Intact Feb 20, 2026 Freedom Capital Markets Raises Freeport-McMoRan to Buy, Cites Copper Supply Tightness Feb 20, 2026 BofA Lifts CF Industries Price Target After Strong Q4 EBITDA; Maintains Underperform Rating Feb 20, 2026 Truist Lifts Tandem Diabetes Price Target as Company Shifts Toward Pharmacy Model Feb 20, 2026